Company Filing History:
Years Active: 2022-2024
Title: Innovations by Rubén Álvaro Bartolomé Conde
Introduction
Rubén Álvaro Bartolomé Conde is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, his work focuses on addressing critical health challenges.
Latest Patents
Rubén's latest patents include methods and compositions for the treatment of IL13Ra2-overexpressing cancer. This invention relates to administering a protein tyrosine phosphatase-1B (PTP1B) inhibitor as part of the treatment. Another significant patent involves an IL13Rα2 peptide and its uses. This invention comprises a peptide with the amino acid sequence SEQ ID NO: 1 or a variant capable of inhibiting IL13/IL13Rα2 signaling. It also includes a fusion protein, nanoparticle, virus-like particle, and pharmaceutical composition that utilize this peptide for treating cancers characterized by increased IL13Rα2 expression, as well as conditions like asthma, atopic dermatitis, or fibrosis.
Career Highlights
Throughout his career, Rubén has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas (CSIC). His research and innovations have contributed to advancements in medical treatments and therapies.
Collaborations
Rubén has collaborated with notable individuals in his field, including José Ignacio Casal Álvarez. These partnerships have further enhanced the impact of his work in the scientific community.
Conclusion
Rubén Álvaro Bartolomé Conde is a distinguished inventor whose work in cancer treatment showcases his commitment to innovation and research. His contributions are paving the way for new therapeutic approaches in medicine.